PL336786A1 - Application of a secretion vector in controlling fertility by means of an orally administered vaccine - Google Patents

Application of a secretion vector in controlling fertility by means of an orally administered vaccine

Info

Publication number
PL336786A1
PL336786A1 PL98336786A PL33678698A PL336786A1 PL 336786 A1 PL336786 A1 PL 336786A1 PL 98336786 A PL98336786 A PL 98336786A PL 33678698 A PL33678698 A PL 33678698A PL 336786 A1 PL336786 A1 PL 336786A1
Authority
PL
Poland
Prior art keywords
application
orally administered
secretion vector
administered vaccine
controlling fertility
Prior art date
Application number
PL98336786A
Other languages
English (en)
Inventor
Peter Donner
Werner Goebel
Andreas Demuth
Ivaylo Gentschev
Juergen Hess
Stefan Kaufmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PL336786A1 publication Critical patent/PL336786A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
PL98336786A 1997-05-07 1998-05-07 Application of a secretion vector in controlling fertility by means of an orally administered vaccine PL336786A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19720761A DE19720761A1 (de) 1997-05-07 1997-05-07 Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung
PCT/EP1998/002679 WO1998050067A2 (de) 1997-05-07 1998-05-07 Verwendung eines sekretionsvektors zur fertilitätskontrolle durch orale vakzinierung

Publications (1)

Publication Number Publication Date
PL336786A1 true PL336786A1 (en) 2000-07-17

Family

ID=7829783

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98336786A PL336786A1 (en) 1997-05-07 1998-05-07 Application of a secretion vector in controlling fertility by means of an orally administered vaccine

Country Status (18)

Country Link
EP (1) EP1015023A1 (et)
JP (1) JP2002501507A (et)
KR (1) KR20010012257A (et)
CN (1) CN1255067A (et)
AU (1) AU7910798A (et)
BG (1) BG103850A (et)
BR (1) BR9809244A (et)
CA (1) CA2288602A1 (et)
DE (1) DE19720761A1 (et)
EE (1) EE9900516A (et)
HU (1) HUP0002752A2 (et)
IL (1) IL132521A0 (et)
IS (1) IS5199A (et)
NO (1) NO995429L (et)
PL (1) PL336786A1 (et)
SK (1) SK151799A3 (et)
TR (1) TR199902671T2 (et)
WO (1) WO1998050067A2 (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206325A1 (de) * 2002-02-14 2003-09-04 Medinnova Ges Med Innovationen Ummantelter Mikroorganismus
US6989160B2 (en) * 2002-03-19 2006-01-24 Council Of Scientific And Industrial Research Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia
EP1882743A4 (en) * 2005-05-12 2012-08-01 Ajinomoto Kk PROTEIN PRODUCTION PROCESS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE177787T1 (de) * 1990-11-21 1999-04-15 Univ Washington Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
US5480799A (en) * 1993-12-10 1996-01-02 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

Also Published As

Publication number Publication date
SK151799A3 (en) 2000-06-12
IS5199A (is) 1999-09-28
BG103850A (en) 2000-05-31
HUP0002752A2 (hu) 2000-12-28
IL132521A0 (en) 2001-03-19
KR20010012257A (ko) 2001-02-15
NO995429D0 (no) 1999-11-05
TR199902671T2 (xx) 2000-09-21
CA2288602A1 (en) 1998-11-12
BR9809244A (pt) 2000-06-27
EE9900516A (et) 2000-06-15
CN1255067A (zh) 2000-05-31
WO1998050067A2 (de) 1998-11-12
NO995429L (no) 2000-01-07
WO1998050067A3 (de) 2000-06-29
JP2002501507A (ja) 2002-01-15
AU7910798A (en) 1998-11-27
WO1998050067A9 (de) 1999-03-25
DE19720761A1 (de) 1998-11-12
EP1015023A1 (de) 2000-07-05

Similar Documents

Publication Publication Date Title
AU4010395A (en) Compositions for increased bioavailability of orally delivered therapeutic agents
PL335974A1 (en) Method of orally administering proteins
IL116492A0 (en) Therapeutic preparations for inhalation
HUP0003972A3 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
HUP9900252A3 (en) Hormonal pharmaceutical combined preparation for contraception and kit
PL341818A1 (en) Hvi-1 tat or its derivatives for prophylactic or therapeutic vaccination
AU1819897A (en) Medicinal prophylactic "trisan"
AU3154395A (en) Contraceptive vaccine
IL112745A0 (en) Formulations for orally administered pharmaceutical agents
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
ZA952983B (en) Boronic peptide derivatives preparation and therapeutic application thereof
PL336786A1 (en) Application of a secretion vector in controlling fertility by means of an orally administered vaccine
CY2228B1 (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
GB9615022D0 (en) Vaccine preparations
AU7449698A (en) Therapeutic agents for respiratory diseases
LT97021A (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
GB9618890D0 (en) An immunogenic determinant
IL115197A (en) Vaccine preparations for preventing vaginal infections
EP0975225A4 (en) FIBROCYTEN-BASED CELLULAR THERAPY FORMULATIONS
PL304816A1 (en) Tiltable rehabilitation table for bringing patients to erect position
GB9624048D0 (en) Cement accelerators
AU2810695A (en) Immunomodulating medicinal agent
ZA9510505B (en) Therapeutic preparations for inhalation
AU694084C (en) Apparatus to manufacture "green" bricks
GB9604873D0 (en) Aid for cardiopulmonary resuscitation